|
Obgemsa - õhukese polümeerikattega tablett (75mg)
|
vibegroon |
G04BD15 |
Pierre Fabre Medicament |
|
Obizur - süstelahuse pulber ja lahusti (500ühik)
|
alfasusoktokog |
B02BD14 |
Baxalta Innovations GmbH |
|
Obodence - süstelahus süstlis (60mg 1ml)
|
denosumab |
M05BX04 |
Samsung Bioepis NL B.V. |
|
Ocrevus
|
okrelizumab |
L04AG08 |
Roche Registration GmbH |
|
Octagam - inf sol 50 mg / ml 50ml; 100ml; 200ml
|
Immunoglobulins, normal human, for intravascular a |
J06BA02 |
OCTAPHARMA AB |
|
Octagam - infusioonilahus (50mg 1ml)
|
immunoglobuliin, intravaskulaarseks kasutamiseks |
J06BA02 |
Octapharma (IP) SPRL |
|
Octagam 10% - infusioonilahus (100mg 1ml)
|
immunoglobuliin, intravaskulaarseks kasutamiseks |
J06BA02 |
Octapharma (IP) SPRL |
|
Octanate 1000 - süstelahuse pulber ja lahusti (1000rü)
|
VIII hüübimisfaktor |
B02BD02 |
OCTAPHARMA AB |
|
Octanate 500 - süstelahuse pulber ja lahusti (500rü)
|
VIII hüübimisfaktor |
B02BD02 |
OCTAPHARMA AB |
|
Octanine - süstelahuse pulber ja lahusti (1000rü)
|
IX hüübimisfaktor |
B02BD04 |
Octapharma (IP) SPRL |
|
Octanine - süstelahuse pulber ja lahusti (500rü)
|
IX hüübimisfaktor |
B02BD04 |
Octapharma (IP) SPRL |
|
Octaplaslg - infusioonilahus (70mg 1ml)
|
inimvereplasma proteiinid |
B05AA86 |
Octapharma (IP) SPRL |
|
Octaplex - infusioonilahuse pulber ja lahusti (1000rü)
|
inimese protrombiinkompleks |
B02BD01 |
Octapharma (IP) SPRL |
|
Octaplex - infusioonilahuse pulber ja lahusti (500rü)
|
inimese protrombiinkompleks |
B02BD01 |
Octapharma (IP) SPRL |
|
Octenidine klosterfrau - loseng (2,6mg)
|
oktenidiin |
R02AA21 |
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mbH |
|
Octenisept - nahalahus (1mg +20mg 1ml)
|
oktenidiin +fenoksüetanool |
D08AJ81 |
Surgitech AS |
|
Octicide - nahasprei, lahus (1mg +20mg 1ml)
|
oktenidiin +fenoksüetanool |
D08AJ81 |
ENEO Pharmaceuticals s.r.o. |
|
Octostim - inj 15mcg / ml amp 1ml n5; n10; amp 2ml n5; n10
|
Desmopressin |
H01BA02 |
Ferring Lääkkeet Oy |
|
Octostim - süstelahus (15mcg 1ml)
|
desmopressiin |
H01BA02 |
FERRING GmbH |
|
Octreotide teva
|
oktreotiid |
H01CB02 |
Teva B.V. |
|
Oczyesa - toimeainet prolongeeritult vabastav süstelahus (20mg 1ml)
|
oktreotiid |
H01CB02 |
Camurus AB |
|
Odefsey - õhukese polümeerikattega tablett (200mg +25mg +25mg)
|
emtritsitabiin +tenofoviiralafenamiid +rilpiviriin |
J05AR19 |
Gilead Sciences Ireland Unlimited Company |
|
Odomzo - kõvakapsel (200mg)
|
sonidegiib |
L01XJ02 |
Sun Pharmaceutical Industries Europe B.V. |
|
Oestrophan inj. ad us. vet. - süstelahus (0,25mg 1ml)
|
kloprostenool |
QG02AD90 |
Bioveta a.s. |
|
Ofev
|
nintedaniib |
L01EX09 |
Boehringer Ingelheim International GmbH |
|
Ofloxin 200 - õhukese polümeerikattega tablett (200mg)
|
ofloksatsiin |
J01MA01 |
Zentiva k.s. |
|
Oftagel - silmageel (2,5mg 1g)
|
karbomeer |
S01XA81 |
Santen Oy |
|
Oftagel - silmageel 2,5mg / g 10g
|
Carbomer |
S01XA81 |
SANTEN OY |
|
Oftan a-pant - silmasalv (20rü +20mg 1g)
|
retinool +dekspantenool |
S01XA80 |
Santen Oy |
|
Oftan a-pant - silmasalv (20tü +20mg 1g)
|
retinool +dekspantenool |
S01XA80 |
Santen Oy |
|
Oftan a-pant - silmasalv 20tü 20mg / g 3,5g
|
Retinol Dexpanthenol |
S01XA80 |
SANTEN OY |
|
Oftan akvakol - silmatilgad, lahus (5mg 1ml)
|
klooramfenikool |
S01AA01 |
Santen Oy |
|
Oftan akvakol - silmatilgad, lahus 5mg / ml 10 ml
|
Chloramphenicol |
S01AA01 |
SANTEN OY |
|
Oftan dexa - silmatilgad, lahus (1mg 1ml)
|
deksametasoon |
S01BA01 |
Santen Oy |
|
Oftan dexa - silmatilgad, lahus 1mg / ml 5 ml
|
Dexamethasone |
S01BA01 |
SANTEN OY |
|
Oftan dexa-chlora - silmasalv (1mg +2mg 1g)
|
deksametasoon +klooramfenikool |
S01CA82 |
Santen Oy |
|
Oftan dexa-chlora - silmasalv 1mg 2mg / g 3,5g
|
Dexamethasone Chloramphenicol |
S01CA82 |
SANTEN OY |
|
Oftan dexa-chlora - silmatilgad, lahus (1mg +2mg 1ml)
|
deksametasoon +klooramfenikool |
S01CA82 |
Santen Oy |
|
Oftan dexa-chlora - silmatilgad, lahus 1mg 2mg / ml 10 ml
|
Dexamethasone Chloramphenicol |
S01CA82 |
SANTEN OY |
|
Oftan timolol - silmatilgad, lahus (5mg 1ml)
|
timolool |
S01ED01 |
SANTEN OY |
|
Oftaquix
|
– |
– |
– |
|
Oftaquix 5 mgml silmatilgad - silmatilgad, lahus (5mg 1ml)
|
levofloksatsiin |
S01AE05 |
Santen Oy |
|
Ogivri
|
trastuzumab |
L01FD01 |
Biosimilar Collaborations Ireland Limited |
|
Ogsiveo
|
nirogatsestaat |
L01XX81 |
Merck Europe B.V. |
|
Ojemda - õhukese polümeerikattega tablett (100mg)
|
tovorafeniib |
L01EC04 |
Ipsen Pharma |
|
Okacin
|
– |
– |
– |
|
Okedi
|
risperidoon |
N05AX08 |
Laboratorios Farmaceuticos Rovi S.A. |
|
Oksaliplatiin ebewe - inf lahuse konts 5mg / 1ml 10ml n1; 10ml n5; 10ml n10; 20ml n1; 40ml n1; 30ml n1; 50ml n1
|
Oxaliplatin |
L01XA03 |
Ebewe Pharma Ges.m.b.H Nfg.KG |
|
Oksaliplatiin ebewe - infusioonilahuse kontsentraat (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Sandoz Pharmaceuticals d.d. |
|
Oksaliplatiin ebewe 5mgml - infusioonilahuse pulber (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Sandoz Pharmaceuticals d.d. |
|
Oksaliplatiin medac
|
– |
– |
– |
|
Oktenidiinfenoksüetanool fgk - nahasprei, lahus 1mg 20mg / ml 50ml; 250ml
|
Octenidine Phenoxyethanol |
D08AJ81 |
FGK Representative Service GmbH |
|
Olansapiin niolib 10mg
|
– |
– |
– |
|
Olansapiin niolib 2,5mg
|
– |
– |
– |
|
Olansapiin niolib 5mg
|
– |
– |
– |
|
Olansapiin niolib 7,5mg
|
– |
– |
– |
|
Olansapiin nyzol 10mg
|
– |
– |
– |
|
Olansapiin nyzol 2,5 mg
|
– |
– |
– |
|
Olansapiin nyzol 5mg
|
– |
– |
– |
|
Olansapiin nyzol 7,5mg
|
– |
– |
– |
|
Olanzapin actavis - õhukese polümeerikattega tablett (10mg)
|
olansapiin |
N05AH03 |
Teva B.V. |
|
Olanzapin actavis - õhukese polümeerikattega tablett (15mg)
|
olansapiin |
N05AH03 |
Actavis Group PTC ehf |
|
Olanzapin actavis - õhukese polümeerikattega tablett (20mg)
|
olansapiin |
N05AH03 |
Actavis Group PTC ehf |
|
Olanzapin actavis - õhukese polümeerikattega tablett (5mg)
|
olansapiin |
N05AH03 |
Teva B.V. |
|
Olanzapin krka - suus dispergeeruv tabl 5mg n28; n56; n14; n35; n70
|
Olanzapine |
N05AH03 |
Krka, d.d., Novo Mesto |
|
Olanzapin krka - suus dispergeeruv tablett (10mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - suus dispergeeruv tablett (15mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - suus dispergeeruv tablett (20mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - suus dispergeeruv tablett (5mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - suus dispergeeruv tablett (7,5mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - tablett (10mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - tablett (15mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - tablett (2,5mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - tablett (20mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - tablett (5mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin krka - tablett (7,5mg)
|
olansapiin |
N05AH03 |
Krka, d.d., Novo mesto |
|
Olanzapin-ratiopharm - tablett (10mg)
|
olansapiin |
N05AH03 |
ratiopharm GmbH |
|
Olanzapine 1a pharma 10mg
|
– |
– |
– |
|
Olanzapine 1a pharma 5mg
|
– |
– |
– |
|
Olanzapine Accord
|
– |
– |
– |
|
Olanzapine accord 10 mg - õhukese polümeerikattega tablett (10mg)
|
olansapiin |
N05AH03 |
Accord Healthcare Limited |
|
Olanzapine accord 15 mg - õhukese polümeerikattega tablett (15mg)
|
olansapiin |
N05AH03 |
Accord Healthcare Limited |
|
Olanzapine accord 5 mg - õhukese polümeerikattega tablett (5mg)
|
olansapiin |
N05AH03 |
Accord Healthcare Limited |
|
Olanzapine actavis - suus dispergeeruv tablett (10mg)
|
olansapiin |
N05AH03 |
Teva B.V. |
|
Olanzapine actavis - suus dispergeeruv tablett (15mg)
|
olansapiin |
N05AH03 |
Teva B.V. |
|
Olanzapine actavis - suus dispergeeruv tablett (20mg)
|
olansapiin |
N05AH03 |
Actavis Group PTC ehf |
|
Olanzapine actavis - suus dispergeeruv tablett (5mg)
|
olansapiin |
N05AH03 |
Teva B.V. |
|
Olanzapine Apotex
|
olanzapine |
N05AH03 |
Apotex Europe B.V.
|
|
Olanzapine aurobindo - suus dispergeeruv tablett (10mg)
|
olansapiin |
N05AH03 |
Aurobindo Pharma (Malta) Limited |
|
Olanzapine glenmark
|
olansapiin |
N05AH03 |
Glenmark Arzneimittel GmbH |
|
Olanzapine Glenmark Europe
|
olanzapine |
N05AH03 |
Glenmark Pharmaceuticals Europe Limited
|
|
OLANZAPINE GSK
|
– |
– |
– |
|
Olanzapine jacobsen
|
– |
– |
– |
|
Olanzapine Medana
|
– |
– |
– |
|
Olanzapine Mylan
|
olanzapine |
N05AH03 |
Generics [UK] Ltd. |
|
Olanzapine Neopharma
|
– |
– |
– |
|
Olanzapine orion 10 mg - suus dispergeeruv tablett (10mg)
|
olansapiin |
N05AH03 |
Orion Corporation |
|
Olanzapine orion 15 mg - suus dispergeeruv tablett (15mg)
|
olansapiin |
N05AH03 |
Orion Corporation |
|
Olanzapine orion 2,5 mg
|
– |
– |
– |
|
Olanzapine orion 20 mg - suus dispergeeruv tablett (20mg)
|
olansapiin |
N05AH03 |
Orion Corporation |
|
Olanzapine orion 5 mg - suus dispergeeruv tablett (5mg)
|
olansapiin |
N05AH03 |
Orion Corporation |
|
Olanzapine orion 7,5 mg
|
– |
– |
– |
|
Olanzapine Polpharma
|
– |
– |
– |
|
Olanzapine sandoz 10mg
|
– |
– |
– |
|
Olanzapine sandoz 5mg
|
– |
– |
– |
|
Olanzapine synthon 10 mg
|
– |
– |
– |
|
Olanzapine synthon 2,5 mg
|
– |
– |
– |
|
Olanzapine synthon 5 mg
|
– |
– |
– |
|
Olanzapine synthon 7,5 mg
|
– |
– |
– |
|
Olanzapine Teva
|
olanzapine |
N05AH03 |
Teva Pharma B.V. |
|
Olanzapine viatris
|
olansapiin |
N05AH03 |
Viatris Limited |
|
Olazax
|
olansapiin |
N05AH03 |
Glenmark Pharmaceuticals s.r.o |
|
Olazax Disperzi
|
olanzapine |
N05AH03 |
Glenmark Pharmaceuticals s.r.o.
|
|
Oleomint - gastroresistentne pehmekapsel (182mg)
|
piparmündiõli |
A03AX83 |
Zaklady Farmaceutyczne Polpharma S.A. |
|
Oleum ricini - suukaudne vedelik (30ml)
|
riitsinusõli |
A06AB05 |
RIGA PHARMACEUTICAL PLANT |
|
Olfen
|
diklofenak |
M02AA15 |
Teva B.V. |
|
Olfen - geel (1%)
|
diklofenak |
M02AA15 |
Teva B.V. |
|
Olfen - geel 1% 50g
|
Diclofenac |
M02AA15 |
MEPHA Lda. |
|
Olfen - ravimplaaster (140mg)
|
diklofenak |
M02AA15 |
Teva B.V. |
|
Olfen depocaps - toimeainet prolongeeritult vabastav kõvakapsel (100mg)
|
diklofenak |
M01AB05 |
Teva B.V. |
|
Olfen depotabs - toimeainet prolongeeritult vabastav tablett (75mg)
|
diklofenak |
M01AB05 |
Teva B.V. |
|
Olfen lactab 50mg
|
– |
– |
– |
|
Olfen rectocaps
|
– |
– |
– |
|
Olfen roll-on
|
– |
– |
– |
|
Olicard 40 mg - toimeainet prolongeeritult vabastav kõvakapsel (40mg)
|
isosorbiitmononitraat |
C01DA14 |
Mylan Healthcare GmbH |
|
Olicard 60 mg - toimeainet prolongeeritult vabastav kõvakapsel (60mg)
|
isosorbiitmononitraat |
C01DA14 |
Mylan Healthcare GmbH |
|
Oliclinomel n4-550 E
|
– |
– |
– |
|
Oliclinomel n6-900 E
|
– |
– |
– |
|
Olimel n12e - infusiooniemulsioon
|
kombinatsioonid |
B05BA10 |
Baxter |
|
Olimel n5e - inf emuls n4; n4; n2
|
Combinations |
B05BA10 |
BAXTER S.A. |
|
Olimel n7 - inf emuls n6; n4; n4
|
Combinations |
B05BA10 |
BAXTER S.A. |
|
Olimel n7e - infusiooniemulsioon
|
kombinatsioonid |
B05BA10 |
BAXTER S.A. |
|
Olimel n9 - infusiooniemulsioon
|
kombinatsioonid |
B05BA10 |
BAXTER S.A. |
|
Olimel n9e - infusiooniemulsioon
|
kombinatsioonid |
B05BA10 |
BAXTER S.A. |
|
Olimel peri n4e - infusiooniemulsioon
|
kombinatsioonid |
B05BA10 |
BAXTER S.A. |
|
Olimestra - õhukese polümeerikattega tablett (10mg)
|
olmesartaanmedoksomiil |
C09CA08 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Olimestra - õhukese polümeerikattega tablett (20mg)
|
olmesartaanmedoksomiil |
C09CA08 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Olimestra - õhukese polümeerikattega tablett (40mg)
|
olmesartaanmedoksomiil |
C09CA08 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Olmedoxlata - tabl 10mg n7; n10; n14; n28; n30; n56; n60; n84; n90; n98; n100
|
Olmesartan medoxomil |
C09CA08 |
Sigillata Limited |
|
Olmedoxlata - tabl 20mg n7; n10; n14; n28; n30; n56; n60; n84; n90; n98; n100
|
Olmesartan medoxomil |
C09CA08 |
Sigillata Limited |
|
Olmedoxlata - tabl 40mg n7; n10; n14; n28; n30; n56; n60; n84; n90; n98; n100
|
Olmesartan medoxomil |
C09CA08 |
G.L. Pharma GmbH |
|
Olmedoxlata - tabl 5mg n7; n10; n14; n28; n30; n56; n60; n84; n90; n98; n100
|
Olmesartan medoxomil |
C09CA08 |
Sigillata Limited |
|
Olmesartan medoxomil 1A Pharma
|
– |
– |
– |
|
Olmesartan medoxomil accord - õhukese polümeerikattega tablett (10mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Accord Healthcare Limited |
|
Olmesartan medoxomil accord - õhukese polümeerikattega tablett (20mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Accord Healthcare Limited |
|
Olmesartan medoxomil accord - õhukese polümeerikattega tablett (40mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Accord Healthcare Limited |
|
Olmesartan medoxomil alembic - õhukese polümeerikattega tablett (10mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomil alembic - õhukese polümeerikattega tablett (20mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomil alembic - õhukese polümeerikattega tablett (40mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomil apotex 10 mg - õhukese polümeerikattega tablett (10mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Apotex Europe B.V. |
|
Olmesartan medoxomil apotex 20 mg - õhukese polümeerikattega tablett (20mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Apotex Europe B.V. |
|
Olmesartan medoxomil apotex 40 mg - õhukese polümeerikattega tablett (40mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Apotex Europe B.V. |
|
Olmesartan medoxomil doc generici - õhukese polümeerikattega tablett (10mg)
|
olmesartaanmedoksomiil |
C09CA08 |
DOC Generici S.r.l. |
|
Olmesartan medoxomil doc generici - õhukese polümeerikattega tablett (20mg)
|
olmesartaanmedoksomiil |
C09CA08 |
DOC Generici S.r.l. |
|
Olmesartan medoxomil doc generici - õhukese polümeerikattega tablett (40mg)
|
olmesartaanmedoksomiil |
C09CA08 |
DOC Generici S.r.l. |
|
Olmesartan medoxomil genericon - õhukese polümeerikattega tablett (10mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Genericon Pharma Gesellschaft m.b.H. |
|
Olmesartan medoxomil genericon - õhukese polümeerikattega tablett (20mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Genericon Pharma Gesellschaft m.b.H. |
|
Olmesartan medoxomil genericon - õhukese polümeerikattega tablett (40mg)
|
olmesartaanmedoksomiil |
C09CA08 |
Genericon Pharma Gesellschaft m.b.H. |
|
Olmesartan medoxomil hct genericon - õhukese polümeerikattega tablett (20mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Genericon Pharma Gesellschaft m.b.H. |
|
Olmesartan medoxomil hct genericon - õhukese polümeerikattega tablett (20mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Genericon Pharma Gesellschaft m.b.H. |
|
Olmesartan medoxomil hct genericon - õhukese polümeerikattega tablett (40mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Genericon Pharma Gesellschaft m.b.H. |
|
Olmesartan medoxomil hct genericon - õhukese polümeerikattega tablett (40mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Genericon Pharma Gesellschaft m.b.H. |
|
Olmesartan medoxomil hydrochlorothiazide alembic - õhukese polümeerikattega tablett (20mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomil hydrochlorothiazide alembic - õhukese polümeerikattega tablett (20mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomil hydrochlorothiazide alembic - õhukese polümeerikattega tablett (40mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomil hydrochlorothiazide alembic - õhukese polümeerikattega tablett (40mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomil sigillata - tabl 10mg n7; n10; n14; n28; n30; n56; n60; n84; n90; n98; n100
|
Olmesartan medoxomil |
C09CA08 |
Sigillata Limited |
|
Olmesartan medoxomil sigillata - tabl 20mg n7; n10; n14; n28; n30; n56; n60; n84; n90; n98; n100
|
Olmesartan medoxomil |
C09CA08 |
Sigillata Limited |
|
Olmesartan medoxomil sigillata - tabl 40mg n7; n10; n14; n28; n30; n56; n60; n84; n90; n98; n100
|
Olmesartan medoxomil |
C09CA08 |
Sigillata Limited |
|
Olmesartan Medoxomil Teva
|
olmesartaanmedoksomiil |
C09CA08 |
Teva B.V. |
|
Olmesartan medoxomil teva pharma
|
olmesartaanmedoksomiil |
C09CA08 |
Teva Pharma B.V. |
|
Olmesartan medoxomilamlodipine accord - õhukese polümeerikattega tablett (20mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Accord Healthcare Limited |
|
Olmesartan medoxomilamlodipine accord - õhukese polümeerikattega tablett (40mg +10mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Accord Healthcare Limited |
|
Olmesartan medoxomilamlodipine accord - õhukese polümeerikattega tablett (40mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Accord Healthcare Limited |
|
Olmesartan medoxomilamlodipine sandoz - õhukese polümeerikattega tablett (20mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Sandoz Pharmaceuticals d.d. |
|
Olmesartan medoxomilamlodipine sandoz - õhukese polümeerikattega tablett (40mg +10mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Sandoz Pharmaceuticals d.d. |
|
Olmesartan medoxomilamlodipine sandoz - õhukese polümeerikattega tablett (40mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Sandoz Pharmaceuticals d.d. |
|
Olmesartan medoxomilamlodipine sandoz - õhukese polümeerikattega tablett (5mg +40mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Sandoz Pharmaceuticals d.d. |
|
Olmesartan medoxomilamlodipine teva - õhukese polümeerikattega tablett (40mg +10mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Teva B.V. |
|
Olmesartan medoxomilamlodipine teva - õhukese polümeerikattega tablett (40mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Teva B.V. |
|
Olmesartan medoxomilamlodipine teva - õhukese polümeerikattega tablett (5mg +40mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Teva B.V. |
|
Olmesartan medoxomilamlodipine zentiva - õhukese polümeerikattega tablett (20mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Zentiva k.s. |
|
Olmesartan medoxomilamlodipine zentiva - õhukese polümeerikattega tablett (40mg +10mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Zentiva k.s. |
|
Olmesartan medoxomilamlodipine zentiva - õhukese polümeerikattega tablett (40mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
Zentiva k.s. |
|
Olmesartan medoxomilamlodipinehct accord
|
olmesartaanmedoksomiil +amlodipiin +hüdroklorotiasiid |
C09DX03 |
Accord Healthcare B.V. |
|
Olmesartan medoxomilamlodipinehydrochlorothiazide alembic
|
olmesartaanmedoksomiil +amlodipiin +hüdroklorotiasiid |
C09DX03 |
Alembic Pharmaceuticals Europe Limited |
|
Olmesartan medoxomilhct sigillata - tabl 20mg 12,5mg n14; n28; n30; n90; n98; n100
|
Olmesartan medoxomil Hydrochlorothiazide |
C09DA08 |
G.L. Pharma GmbH |
|
Olmesartan medoxomilhct sigillata - tabl 20mg 25mg n14; n28; n30; n90; n98; n100
|
Olmesartan medoxomil Hydrochlorothiazide |
C09DA08 |
G.L. Pharma GmbH |
|
Olmesartan medoxomilhct sigillata - tabl 40mg 12,5mg n14; n28; n30; n90; n98; n100
|
Olmesartan medoxomil Hydrochlorothiazide |
C09DA08 |
G.L. Pharma GmbH |
|
Olmesartan medoxomilhct sigillata - tabl 40mg 25mg n14; n28; n30; n90; n98; n100
|
Olmesartan medoxomil Hydrochlorothiazide |
C09DA08 |
G.L. Pharma GmbH |
|
Olmesartan medoxomilhctz teva
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA86 |
Teva B.V. |
|
Olmesartan medoxomilhydrochlorothiazide apotex 20 mg12,5 mg - õhukese polümeerikattega tablett (20mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Apotex Europe B.V. |
|
Olmesartan medoxomilhydrochlorothiazide apotex 20 mg25 mg - õhukese polümeerikattega tablett (20mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Apotex Europe B.V. |
|
Olmesartan medoxomilhydrochlorothiazide apotex 40 mg12,5 mg - õhukese polümeerikattega tablett (40mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Apotex Europe B.V. |
|
Olmesartan medoxomilhydrochlorothiazide apotex 40 mg25 mg - õhukese polümeerikattega tablett (40mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA08 |
Apotex Europe B.V. |
|
Olmis
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA86 |
Teva B.V. |
|
Olopatadine unimed pharma - silmatilgad, lahus (1mg 1ml)
|
olopatadiin |
S01GX09 |
Unimed Pharma spol. s r.o. |
|
Olopeg - suukaudse lahuse kontsentraat (52,5g +1,95g +1,65g +0,73g +0,19g 100ml)
|
makrogool +naatriumtsitraat +sidrunhape +naatriumkloriid +kaaliumkloriid |
A06AD80 |
MIP Pharma GmbH |
|
Olopeg - suukaudse lahuse kontsentraat (525mg +19,5mg +16,5mg +7,3mg +1,9mg 1ml)
|
makrogool +naatriumtsitraat +sidrunhape +naatriumkloriid +kaaliumkloriid |
A06AD80 |
MIP Pharma GmbH |
|
Olpressor
|
– |
– |
– |
|
Olsert hct sigillata - õhukese polümeerikattega tablett (20mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA86 |
DOC Generici S.r.l. |
|
Olsert hct sigillata - õhukese polümeerikattega tablett (20mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA86 |
DOC Generici S.r.l. |
|
Olsert hct sigillata - õhukese polümeerikattega tablett (40mg +12,5mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA86 |
DOC Generici S.r.l. |
|
Olsert hct sigillata - õhukese polümeerikattega tablett (40mg +25mg)
|
olmesartaanmedoksomiil +hüdroklorotiasiid |
C09DA86 |
DOC Generici S.r.l. |
|
Olsitri
|
olmesartaanmedoksomiil +amlodipiin +hüdroklorotiasiid |
C09DX03 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Olssa - õhukese polümeerikattega tablett (20mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Olssa - õhukese polümeerikattega tablett (40mg +10mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Olssa - õhukese polümeerikattega tablett (40mg +5mg)
|
olmesartaanmedoksomiil +amlodipiin |
C09DB02 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Oltar 1mg - tablett (1mg)
|
glimepiriid |
A10BB12 |
Berlin-Chemie AG (Menarini Group) |
|
Oltar 2 mg - tablett (2mg)
|
glimepiriid |
A10BB12 |
Berlin-Chemie AG (Menarini Group) |
|
Oltar 3 mg - tablett (3mg)
|
glimepiriid |
A10BB12 |
Berlin-Chemie AG (Menarini Group) |
|
Oltar 4mg
|
– |
– |
– |
|
Oltar 6mg
|
– |
– |
– |
|
Olteron
|
tramadool |
N02AX02 |
KRKA tovarna zdravil d.d. Novo mesto |
|
Olumiant
|
baritsitiniib |
L04AF02 |
Eli Lilly Nederland B.V. |
|
Olvion - õhukese polümeerikattega tablett (100mg)
|
sildenafiil |
G04BE03 |
Medochemie Ltd. |
|
Olvion - õhukese polümeerikattega tablett (50mg)
|
sildenafiil |
G04BE03 |
Medochemie Ltd. |
|
Omacor - pehmekapsel (1000mg)
|
oomega-3-rasvhappe etüülestrid 90 |
C10AX80 |
Ideal Trade Links UAB |
|
Omar
|
– |
– |
– |
|
Omebel - gastroresistentne kapsel 20mg n14; n28; n30; n56; n60
|
Omeprazole |
A02BC01 |
Septinta S.P.R.L. |
|
Omediprol
|
– |
– |
– |
|
Omeflux - gastroresistentne kõvakapsel (10mg)
|
omeprasool |
A02BC01 |
Actavis Group PTC ehf |
|
Omeflux - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
Actavis Group PTC ehf |
|
Omegaven - infusiooniemulsioon
|
rasvemulsioonid |
B05BA02 |
FRESENIUS KABI Deutschland GmbH |
|
Omep 10 mg
|
– |
– |
– |
|
Omep 20mg - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
Sandoz Pharmaceuticals d.d. |
|
Omep 40mg - gastroresistentne kõvakapsel (40mg)
|
omeprasool |
A02BC01 |
Sandoz Pharmaceuticals d.d. |
|
Omep uno - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
Sandoz Pharmaceuticals d.d. |
|
Omeprazol sandoz 10 mg
|
– |
– |
– |
|
Omeprazol sandoz 20 mg
|
– |
– |
– |
|
Omeprazol sandoz 40 mg
|
– |
– |
– |
|
Omeprazol-ratiopharm NT
|
– |
– |
– |
|
Omeprazole accord - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
Accord Healthcare Limited |
|
Omeprazole accord - gastroresistentne kõvakapsel (40mg)
|
omeprasool |
A02BC01 |
Accord Healthcare Limited |
|
Omeprazole aurobindo - gastroresistentne kapsel 10mg n7; n14; n15; n28; n30; n50; n56; n60; n98; n100; n500
|
Omeprazole |
A02BC01 |
Aurobindo Pharma (Malta) Limited |
|
Omeprazole aurobindo - gastroresistentne kapsel 20mg n7; n14; n15; n28; n30; n50; n56; n60; n98; n100; n500; n1; n90; n250; n1000
|
Omeprazole |
A02BC01 |
Aurobindo Pharma (Malta) Limited |
|
Omeprazole aurobindo - gastroresistentne kapsel 40mg n7; n14; n15; n28; n30; n50; n56; n60; n98; n100; n500
|
Omeprazole |
A02BC01 |
Aurobindo Pharma (Malta) Limited |
|
Omeprazole grindeks - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
AS Grindeks |
|
Omeprazole olainfarm - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
AS ?Olainfarm? |
|
Omeprazole olpha - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
Olpha AS |
|
Omeprazole sandoz - infusioonilahuse pulber (40mg)
|
omeprasool |
A02BC01 |
Sandoz Pharmaceuticals d.d. |
|
Omeprazole stada 10 mg - gastroresistentne kõvakapsel (10mg)
|
omeprasool |
A02BC01 |
Stada Arzneimittel AG |
|
Omeprazole stada 20 mg - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
Stada Arzneimittel AG |
|
Omeprazole stada 40 mg - gastroresistentne kõvakapsel (40mg)
|
omeprasool |
A02BC01 |
Stada Arzneimittel AG |
|
Omeprazole uqfar 20mg - gastroresistentne kapsel 20mg n7; n14; n28; n30; n60; n500
|
Omeprazole |
A02BC01 |
Uquifa Union Quimico Farmaceutica, S.A. |
|
Omeprazole zentiva - kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
Zentiva k.s. |
|
Omeprazole-ratiopharm - gastroresistentne kõvakapsel (20mg)
|
omeprasool |
A02BC01 |
ratiopharm GmbH |
|
Omipro
|
– |
– |
– |
|
Omjjara
|
momelotiniib |
L01EJ04 |
GlaxoSmithKline Trading Services Limited |
|
Omlyclo
|
omalizumab |
R03DX05 |
Celltrion Healthcare Hungary Kft. |
|
Omnic
|
– |
– |
– |
|
Omnic tocas - prolong tabl 0,4mg n30; n90
|
Tamsulosin |
G04CA02 |
Astellas Pharma a/s |
|
Omnicef
|
– |
– |
– |
|
Omnipaque - süstelahus (518mg 1ml)
|
joheksool |
V08AB02 |
GE Healthcare AS |
|
Omnipaque - süstelahus (647mg 1ml)
|
joheksool |
V08AB02 |
GE Healthcare AS |
|
Omnipaque - süstelahus (755mg 1ml)
|
joheksool |
V08AB02 |
GE Healthcare AS |
|
Omniscan - süstelahus (0,5mmol 1ml)
|
gadodiamiid |
V08CA03 |
GE Healthcare AS |
|
Omnitrope
|
somatropin |
H01AC01 |
Sandoz GmbH |
|
Omolin
|
– |
– |
– |
|
Omsal - toimeainet prolongeeritult vabastav kõvakapsel (0,4mg)
|
tamsulosiin |
G04CA02 |
Gedeon Richter Plc. |
|
Omvoh
|
mirikizumab |
L04AC24 |
Eli Lilly Nederland B.V. |
|
Onbrez Breezhaler
|
indakaterool |
R03AC18 |
Novartis Europharm Ltd.
|
|
Oncaspar - süste-/infusioonilahuse pulber (3750ühik)
|
pegaspargaas |
L01XX24 |
Les Laboratoires Servier |
|
Ondansetron accord 2mgml - süste- või inf lahus 2mg / ml 2ml n10; 4ml n10; 2ml n5; 4ml n5
|
Ondansetron |
A04AA01 |
Accord Healthcare Limited |
|
Ondansetron accord 2mgml - süste-/infusioonilahus (2mg 1ml)
|
ondansetroon |
A04AA01 |
Accord Healthcare Limited |
|
Ondansetron basi - süste-/infusioonilahus (2mg 1ml)
|
ondansetroon |
A04AA01 |
Laboratorios Basi Industria Farmaceutica S.A. |
|
Ondansetron baxter - süstelahus (2mg 1ml)
|
ondansetroon |
A04AA01 |
Baxter Holding B.V. |
|
Ondansetron bmm pharma
|
– |
– |
– |
|
Ondansetron claris
|
– |
– |
– |
|
Ondansetron claris - süstelahus (2mg 1ml)
|
ondansetroon |
A04AA01 |
Claris Lifesciences (UK) Limited |
|
Ondansetron kabi
|
ondansetroon |
A04AA01 |
Fresenius Kabi Polska Sp. z o.o. |
|
Ondansetron kalceks - süste-/infusioonilahus (2mg 1ml)
|
ondansetroon |
A04AA01 |
Kalceks AS |
|
Ondansetron sandoz
|
– |
– |
– |
|
Ondexxya - infusioonilahuse pulber (200mg)
|
alfaandeksaneet |
V03AB38 |
AstraZeneca AB |
|
Ondibta - süstelahus pen-süstlis (100ühik 1ml)
|
glargiin-insuliin |
A10AE04 |
Sandoz GmbH |
|
Onduarp
|
telmisartan /amlodipine besilate |
C09DB04 |
Boehringer Ingelheim International GmbH |
|
Onelar - gastroresistentne kõvakapsel (30mg)
|
duloksetiin |
N06AX21 |
Medochemie Ltd. |
|
Onelar - gastroresistentne kõvakapsel (60mg)
|
duloksetiin |
N06AX21 |
Medochemie Ltd. |
|
Onerji - infusioonilahus (60mg +7,5mg 1ml)
|
levodopa +karbidopa |
N04BA81 |
Tanabe Pharma GmbH |
|
Ongentys
|
opikapoon |
N04BX04 |
Bial - Portela & Ca S.A. |
|
Onglyza
|
saksagliptiin |
A10BH03 |
Astrazeneca AB |
|
Onivyde pegylated liposomal - infusioonilahuse kontsentraat (4,3mg 1ml)
|
irinotekaan |
L01CE02 |
Les Laboratoires Servier |
|
Onkotrone - infusioonilahuse kontsentraat (2mg 1ml)
|
mitoksantroon |
L01DB07 |
OÜ Baxter Estonia |
|
Onkotrone - süstelahus (2mg 1ml)
|
mitoksantroon |
L01DB07 |
Baxter Oncology GmbH |
|
Onpattro - infusioonilahuse kontsentraat (2mg 1ml)
|
patisiraan |
N07XX12 |
Alnylam Netherlands B.V. |
|
Ontilyv
|
opikapoon |
N04BX04 |
Bial - Portela & Ca S.A. |
|
Ontozry
|
tsenobamaat |
N03AX25 |
Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.p.A. |
|
Ontruzant
|
trastuzumab |
L01FD01 |
Samsung Bioepis NL B.V. |
|
Onureg
|
asatsitidiin |
L01BC07 |
Bristol-Myers Squibb Pharma EEIG |
|
Onytec - ravimküünelakk (80mg 1g)
|
tsiklopiroks |
D01AE14 |
Polichem SA |
|
OPATANOL
|
olopatadine hydrochloride |
S01GX09 |
Novartis Europharm Limited |
|
Opdivo
|
nivolumab |
L01FF01 |
Bristol-Myers Squibb Pharma EEIG |
|
Opdualag - infusioonilahuse kontsentraat (240mg +80mg 20ml)
|
nivolumab +relatlimab |
L01FY02 |
Bristol-Myers Squibb Pharma EEIG |
|
Opexa
|
bilastiin |
S01GX13 |
Menarini International Operations Luxembourg S.A. |
|
Opexa - suukaudne lahus (2,5mg 1ml)
|
bilastiin |
R06AX29 |
Menarini International Operations Luxembourg S.A. |
|
Opexa - suus dispergeeruv tablett (10mg)
|
bilastiin |
R06AX29 |
Menarini International Operations Luxembourg S.A. |
|
Opexa - tablett (20mg)
|
bilastiin |
R06AX29 |
Menarini International Operations Luxembourg S.A. |
|
Opfolda - kõvakapsel (65mg)
|
miglustaat |
A16AX06 |
Amicus Therapeutics Europe Limited |
|
Opgenra
|
eptotermin alfa |
M05BC02 |
Olympus Biotech International Limited |
|
Ophenic - nahasprei, lahus (1mg +20mg 1ml)
|
oktenidiin +fenoksüetanool |
D08AJ81 |
Schülke & Mayr GmbH |
|
Ophtaclin vet - silmasalv (9,3mg 1g)
|
kloortetratsükliin |
QS01AA02 |
Le Vet. Beheer B.V. |
|
Opiodur
|
– |
– |
– |
|
Oprymea
|
pramipexole dihydrochloride monohydrate |
N04BC05 |
Krka, d.d., Novo mesto |
|
Opsumit
|
matsitentaan |
C02KX04 |
Janssen - Cilag International |
|
Optaflu
|
Influenza virus surface antigens (haemagglutinin and neuraminidase), inactivated, of the following strains:
A/California/7/2009 (H1N1)pdm09 - like strain used A/Brisbane/10/2010 wild type Victoria/361/2011 (H3N2) - like strain used (NYMC X-223A) derived from A/Texas/50/2012 B/Massachusetts/2/2012 |
J07BB02 |
Novartis Vaccines and Diagnostics GmbH |
|
Optimark
|
gadoversetamide |
V08CA06 |
Mallinckrodt Deutschland GmbH |
|
Optison
|
perflutren |
V08DA01 |
GE Healthcare AS |
|
Optisulin
|
insulin glargine |
A10AE04 |
sanofi-aventis Deutschland GmbH |
|
Optivate - inj lahuse pulber ja lahusti 100rü / 1ml pulber 250rü n1 ja lahusti 2,5ml n1; 500rü n1 ja lahusti 5ml n1; 1000rü n1 ja lahusti 10ml n1
|
Human coagulation factor VIII |
B02BD02 |
Bio Products Laboratory Limited |
|
Optruma
|
raloxifene hydrochloride |
G03XC01 |
Eli Lilly Nederland B.V. |
|
Opuviz
|
aflibertsept |
S01LA05 |
Samsung Bioepis NL B.V. |
|
Opzelura - kreem (15mg 1g)
|
ruksolitiniib |
D11AH09 |
Incyte Biosciences Distribution B.V. |
|
ORALAIR
|
– |
– |
– |
|
Oralair 100 ir
|
– |
– |
– |
|
Oralair 100 ir & 300 ir - keelealune tablett (100ir/300ir)
|
heintaimede õietolm |
V01AA02 |
STALLERGENES |
|
Oralair 300 ir - keelealune tablett (300ir)
|
heintaimede õietolm |
V01AA02 |
STALLERGENES |
|
Orbenin edc - intramammaarsuspensioon (600mg 3.6g)
|
kloksatsilliin |
QJ51CF02 |
Zoetis Belgium S.A. |
|
Orbeseal - intramammaarsuspensioon (2,6g 4g)
|
vismutsubnitraat |
QG52XX80 |
Zoetis Belgium S.A. |
|
Ordspono
|
odronekstamab |
L01FX34 |
Regeneron Ireland Designated Activity Company |
|
Orebriton
|
tikagreloor |
B01AC24 |
Zentiva k.s. |
|
Orencia
|
abatatsept |
L04AA24 |
Bristol-Myers Squibb Pharma EEIG |
|
Orfadin
|
nitisinoon |
A16AX04 |
Swedish Orphan Biovitrum International AB |
|
Orfiril - inj 100mg / ml 3ml n5
|
Valproic acid |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril - süstelahus (100mg 1ml)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril 150 - gastroresistentne tablett (150mg)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril 300 - gastroresistentne tablett (300mg)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril 600 - gastroresistentne tablett (600mg)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril long 1000 mg - prolong gran 1000mg n100
|
Valproic acid |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril long 150 mg - toimeainet prolongeeritult vabastav kõvakapsel (150mg)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril long 300 mg - toimeainet prolongeeritult vabastav kõvakapsel (300mg)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril long 500 mg - toimeainet prolongeeritult vabastavad graanulid (500mg)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril saft - peroraalne lahus 60mg / ml 250ml
|
Valproic acid |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orfiril saft - suukaudne lahus (60mg 1ml)
|
valproehape |
N03AG01 |
Desitin Arzneimittel GmbH |
|
Orgalutran
|
ganirelix |
H01CC01 |
Organon N.V. |
|
Orgovyx - õhukese polümeerikattega tablett (120mg)
|
relugoliks |
L02BX04 |
Accord Healthcare S.L.U. |
|
Orindille - õhukese polümeerikattega tablett (3mg +0,02mg)
|
drospirenoon +etünüülöstradiool |
G03AA12 |
UAB Orivas |
|
Orindille - õhukese polümeerikattega tablett (3mg +0,03mg)
|
drospirenoon +etünüülöstradiool |
G03AA12 |
UAB Orivas |
|
Orkambi
|
ivakaftoor +lumakaftoor |
R07AX30 |
Vertex Pharmaceuticals (Ireland) Limited |
|
Orladeyo - kõvakapsel (150mg)
|
berotralstaat |
B06AC06 |
BioCryst Ireland Limited |
|
Orlistat
|
– |
– |
– |
|
Orlistat polpharma 120 mg - caps 120mg n21; n42; n84
|
Orlistat |
A08AB01 |
Pharmaceutical Works Polpharma S.A. |
|
Orlistat polpharma 60mg - caps 60mg n42; n60; n84; n90
|
Orlistat |
A08AB01 |
Pharmaceutical Works Polpharma S.A. |
|
Orlistat sandoz 120 mg - caps 120mg n21; n42; n84; n252
|
Orlistat |
A08AB01 |
Sandoz Pharmaceuticals d.d. |
|
Orlistat sandoz 120 mg - kõvakapsel (120mg)
|
orlistaat |
A08AB01 |
Sandoz Pharmaceuticals d.d. |
|
Orlistat sandoz 60mg - caps 60mg n42; n60; n84; n90; n21; n126; n252
|
Orlistat |
A08AB01 |
Sandoz Pharmaceuticals d.d. |
|
Orlistat sandoz 60mg - kõvakapsel (60mg)
|
orlistaat |
A08AB01 |
Sandoz Pharmaceuticals d.d. |
|
Ornique - vaginaalravivahend (120mcg +15mcg 24h)
|
etonogestreel +etünüülöstradiool |
G02BB01 |
UAB Exeltis Baltics |
|
Ornivac nd+ib2+eds - süsteemulsioon (0,5ml +0,5ml +0,5ml 1annust)
|
Newcastle'i tõve viirus-/paramüksoviirusvaktsiin +lindude nakkava bronhiidi viirusvaktsiin +lindude adenoviirusvaktsiin |
QI01AA13 |
Bioveta a.s. |
|
Oronazol
|
– |
– |
– |
|
Oroperidys 10 mg
|
– |
– |
– |
|
Oroperidys 10 mg - suus dispergeeruv tablett (10mg)
|
domperidoon |
A03FA03 |
Pierre Fabre Medicament |
|
Orphacol
|
koolhape |
A05AA03 |
Theravia |
|
Orserdu
|
elatsestrant |
L02BA04 |
Stemline Therapeutics B.V. |
|
Ortofen - salv (20mg 1g)
|
diklofenak |
M02AA15 |
Grindeks AS |
|
Orungal
|
– |
– |
– |
|
Osenvelt - süstelahus (120mg 1.7ml)
|
denosumab |
M05BX04 |
Celltrion Healthcare Hungary Kft. |
|
Osigraft
|
eptotermin alfa |
M05BC02 |
Olympus Biotech International Limited |
|
Oslif Breezhaler
|
indakaterool |
R03AC18 |
Novartis Europharm Ltd.
|
|
Osmetil
|
metüülfenidaat |
N06BA04 |
Exeltis Baltics UAB |
|
Ospamox - õhukese polümeerikattega tablett (1000mg)
|
amoksitsilliin |
J01CA04 |
Sandoz Pharmaceuticals d.d. |
|
Ospamox - õhukese polümeerikattega tablett (500mg)
|
amoksitsilliin |
J01CA04 |
Sandoz Pharmaceuticals d.d. |
|
Ospamox 250 mg5 ml - suukaudse susp pulber 50mg / ml 60ml; 100ml
|
Amoxicillin |
J01CA04 |
Sandoz GmbH |
|
Ospamox 250 mg5 ml - suukaudse suspensiooni pulber (50mg 1ml)
|
amoksitsilliin |
J01CA04 |
Sandoz GmbH |
|
Ospen - õhukese polümeerikattega tablett (1000000rü)
|
fenoksümetüülpenitsilliin |
J01CE02 |
Sandoz GmbH |
|
Ospen - suukaudne suspensioon (400000rü 5ml)
|
fenoksümetüülpenitsilliin |
J01CE02 |
Sandoz GmbH |
|
Ospolot - suukaudne suspensioon (20mg 1ml)
|
sultiaam |
N03AX03 |
Desitin Arzneimittel GmbH |
|
Osqay - süstelahus süstlis (60mg 1ml)
|
denosumab |
M05BX04 |
Theramex Ireland Limited |
|
Osseor
|
strontium ranelate |
M05BX03 |
Les Laboratoires Servier |
|
Ossica
|
– |
– |
– |
|
Ossinat
|
– |
– |
– |
|
Ostiral 60 mg
|
– |
– |
– |
|
Osvaren - tabl 435mg 235mg n180
|
Calcium acetate Magnesium carbonate, heavy |
V03AE04 |
Fresenius Medical Care Nephrologica Deutschland GmbH |
|
Osvyrti - süstelahus süstlis (60mg 1ml)
|
denosumab |
M05BX04 |
Accord Healthcare S.L.U. |
|
Otezla
|
apremilast |
L04AA32 |
Amgen Europe B.V. |
|
Otidolo pekana - kõrvatilgad, lahus
|
homöopaatilised preparaadid |
V03AX82 |
PEKANA Naturheilmittel GmbH |
|
Otoxolan - kõrvatilgad, suspensioon (0,9mg +3mg +10mg 1ml)
|
deksametasoon +marbofloksatsiin +klotrimasool |
QS02CA85 |
KRKA d.d., Novo mesto |
|
Otrinazil - ninasprei, lahus (1mg +50mg 1ml)
|
ksülometasoliin +dekspantenool |
R01AB85 |
Haleon Hungary Kft. |
|
Otrivin - ninasprei, lahus (1mg 1ml)
|
ksülometasoliin |
R01AA07 |
Haleon Hungary Kft. |
|
Otrivin - ninasprei, lahus 1mg / 1ml 10ml n1
|
Xylometazoline |
R01AA07 |
Novartis Finland OY |
|
Otrivin - ninatilgad, lahus (0,5mg 1ml)
|
ksülometasoliin |
R01AA07 |
Haleon Hungary Kft. |
|
Otrivin - ninatilgad, lahus (1mg 1ml)
|
ksülometasoliin |
R01AA07 |
Haleon Hungary Kft. |
|
Otrivin menthol - ninasprei, lahus (1mg 1ml)
|
ksülometasoliin |
R01AA07 |
Haleon Hungary Kft. |
|
Otrivin plus - ninasprei, lahus (1mg +50mg 1ml)
|
ksülometasoliin +dekspantenool |
R01AB85 |
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited |
|
Otrivin total - ninasprei, lahus (0,5mg +0,6mg 1ml)
|
ksülometasoliin +ipratroopiumbromiid |
R01AB83 |
Haleon Hungary Kft. |
|
Otulfi
|
ustekinumab |
L04AC05 |
Fresenius Kabi Deutschland GmbH |
|
Ovaleap
|
alfafollitropiin |
G03GA05 |
Theramex Ireland Limited |
|
Ovarelin - süstelahus (50mcg 1ml)
|
gonadoreliin |
QH01CA01 |
Ceva Santé Animale |
|
Ovestin - vaginaalsuposiit (500mcg)
|
östriool |
G03CA04 |
Aspen Pharma Trading Limited |
|
Ovitrelle
|
choriogonadotropin alfa |
G03GA08 |
Merck Serono Europe Limited |
|
Ovulike - süstelahus (4mcg 1ml)
|
busereliin |
QH01CA90 |
T.P. Whelehan Son & Co. Ltd. |
|
Oxacillin auxilia - süste-/infusioonilahuse pulber (1000mg)
|
oksatsilliin |
J01CF04 |
Auxilia Pharma OÜ |
|
Oxaliplatin Accord
|
– |
– |
– |
|
Oxaliplatin accord 5 mgml - infusioonilahuse kontsentraat (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Accord Healthcare Limited |
|
Oxaliplatin actavis - infusioonilahuse kontsentraat (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Actavis Group PTC ehf |
|
Oxaliplatin bmm pharma
|
– |
– |
– |
|
Oxaliplatin Hospira
|
– |
– |
– |
|
Oxaliplatin hospira - infusioonilahuse kontsentraat (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Hospira UK Limited |
|
Oxaliplatin hospira 5 mgml - inf lahuse pulber 5mg / ml 50mg n1; 100mg n1
|
Oxaliplatin |
L01XA03 |
Hospira UK Limited |
|
Oxaliplatin hospira 5 mgml - infusioonilahuse pulber (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Hospira UK Limited |
|
Oxaliplatin Kabi
|
– |
– |
– |
|
Oxaliplatin kabi 5mgml - infusioonilahuse kontsentraat (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Fresenius Kabi Polska Sp. z o.o. |
|
Oxaliplatin medac
|
– |
– |
– |
|
Oxaliplatin mylan - inf conc 5mg / 1ml 10ml n1; 20ml n1; 40ml n1
|
Oxaliplatin |
L01XA03 |
Mylan S.A.S |
|
Oxaliplatin mylan - inf lahuse pulber 5mg / 1ml 50mg n1; 100mg n1
|
Oxaliplatin |
L01XA03 |
Mylan S.A.S |
|
Oxaliplatin pharmaswiss
|
– |
– |
– |
|
Oxaliplatin-teva 5mgml - infusioonilahuse kontsentraat (5mg 1ml)
|
oksaliplatiin |
L01XA03 |
Teva B.V. |
|
Oxazepam
|
– |
– |
– |
|
Oxazepam actavis - tablett (10mg)
|
oksasepaam |
N05BA04 |
Actavis Group PTC ehf |
|
Oxcarbazepine teva 150 mg
|
– |
– |
– |
|
Oxcarbazepine teva 300 mg - õhukese polümeerikattega tablett (300mg)
|
okskarbasepiin |
N03AF02 |
Teva Pharma B.V. |
|
Oxcarbazepine teva 600 mg - õhukese polümeerikattega tablett (600mg)
|
okskarbasepiin |
N03AF02 |
Teva Pharma B.V. |
|
Oxervate - silmatilgad, lahus (20mcg 1ml)
|
tsenegermiin |
S01XA24 |
Dompe Farmaceutici S.p.A. |
|
Oxidraxib - õhukese polümeerikattega tablett (120mg)
|
etorikoksiib |
M01AH05 |
PharmaSwiss Ceska republika s.r.o. |
|
Oxidraxib - õhukese polümeerikattega tablett (60mg)
|
etorikoksiib |
M01AH05 |
PharmaSwiss Ceska republika s.r.o. |
|
Oxidraxib - õhukese polümeerikattega tablett (90mg)
|
etorikoksiib |
M01AH05 |
PharmaSwiss Ceska republika s.r.o. |
|
Oxis turbuhaler - inhal pulber 4,5mcg / annuses 60annust
|
Formoterol |
R03AC13 |
AstraZeneca AB |
|
Oxis turbuhaler - inhal pulber 9mcg / annuses 60annust
|
Formoterol |
R03AC13 |
AstraZeneca AB |
|
Oxis turbuhaler - inhalatsioonipulber (4,5mcg 1annus)
|
formoterool |
R03AC13 |
Astrazeneca AB |
|
Oxis turbuhaler - inhalatsioonipulber (4,5mcg 1annust)
|
formoterool |
R03AC13 |
AstraZeneca AB |
|
Oxis turbuhaler - inhalatsioonipulber (9mcg 1annust)
|
formoterool |
R03AC13 |
AstraZeneca AB |
|
Oxlumo - süstelahus (94,5mg 0.5ml)
|
lumasiraan |
A16AX18 |
Alnylam Netherlands B.V. |
|
Oxsynia - toimeainet prolongeeritult vabastav tablett (10mg +5mg)
|
oksükodoon +naloksoon |
N02AA55 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxsynia - toimeainet prolongeeritult vabastav tablett (15mg +7,5mg)
|
oksükodoon +naloksoon |
N02AA55 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxsynia - toimeainet prolongeeritult vabastav tablett (2,5mg +1,25mg)
|
oksükodoon +naloksoon |
N02AA55 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxsynia - toimeainet prolongeeritult vabastav tablett (20mg +10mg)
|
oksükodoon +naloksoon |
N02AA55 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxsynia - toimeainet prolongeeritult vabastav tablett (30mg +15mg)
|
oksükodoon +naloksoon |
N02AA55 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxsynia - toimeainet prolongeeritult vabastav tablett (40mg +20mg)
|
oksükodoon +naloksoon |
N02AA55 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxsynia - toimeainet prolongeeritult vabastav tablett (5mg +2,5mg)
|
oksükodoon +naloksoon |
N02AA55 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxycodon Lannacher
|
– |
– |
– |
|
Oxycodone kalceks
|
oksükodoon |
N02AA05 |
Kalceks AS |
|
Oxycodone Lannacher
|
– |
– |
– |
|
Oxycodone lannacher 10 mg - toimeainet prolongeeritult vabastav tablett (10mg)
|
oksükodoon |
N02AA05 |
G.L. Pharma GmbH |
|
Oxycodone lannacher 20 mg - toimeainet prolongeeritult vabastav tablett (20mg)
|
oksükodoon |
N02AA05 |
G.L. Pharma GmbH |
|
Oxycodone lannacher 40 mg - toimeainet prolongeeritult vabastav tablett (40mg)
|
oksükodoon |
N02AA05 |
G.L. Pharma GmbH |
|
Oxycodone lannacher 5 mg - toimeainet prolongeeritult vabastav tablett (5mg)
|
oksükodoon |
N02AA05 |
G.L. Pharma GmbH |
|
Oxycodone lannacher 80 mg - toimeainet prolongeeritult vabastav tablett (80mg)
|
oksükodoon |
N02AA05 |
G.L. Pharma GmbH |
|
Oxycodone vitabalans - õhukese polümeerikattega tablett (10mg)
|
oksükodoon |
N02AA05 |
VITABALANS OY |
|
Oxycodone vitabalans - õhukese polümeerikattega tablett (5mg)
|
oksükodoon |
N02AA05 |
VITABALANS OY |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (10mg +20mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (10mg +5mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (15mg +30mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (20mg +10mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (20mg +40mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (30mg +15mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (40mg +20mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (5mg +10mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycodonenaloxone g.l. pharma - toimeainet prolongeeritult vabastav tablett (5mg +2,5mg)
|
oksükodoon +naloksoon |
N02AA55 |
G.L. Pharma GmbH |
|
Oxycontin 10 mg - toimeainet prolongeeritult vabastav tablett (10mg)
|
oksükodoon |
N02AA05 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxycontin 20 mg - toimeainet prolongeeritult vabastav tablett (20mg)
|
oksükodoon |
N02AA05 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxycontin 40 mg - toimeainet prolongeeritult vabastav tablett (40mg)
|
oksükodoon |
N02AA05 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxycontin 80 mg - toimeainet prolongeeritult vabastav tablett (80mg)
|
oksükodoon |
N02AA05 |
MUNDIPHARMA Ges.m.b.H. |
|
Oxyto-kel - süstelahus (10rü 1ml)
|
oksütotsiin |
QH01BB02 |
Kela N.V. |
|
Oxytobel - süstelahus (10rü/ml 1ml)
|
oksütotsiin |
QH01BB02 |
Bela-Pharm GmbH & Co. KG |
|
Oxytocin bioveta - süstelahus (5rü 1ml)
|
oksütotsiin |
QH01BB02 |
Bioveta a.s. |
|
Oxytocin-grindeks - süste-/infusioonilahus (5rü 1ml)
|
oksütotsiin |
H01BB02 |
Grindeks AS |
|
Oxytrol
|
– |
– |
– |
|
Oyavas - infusioonilahuse kontsentraat (25mg 1ml)
|
bevatsizumab |
L01FG01 |
Stada Arzneimittel AG |
|
Ozapex
|
– |
– |
– |
|
Ozawade
|
pitolisant |
N07XX11 |
Bioprojet Pharma |
|
Ozempic
|
semaglutiid |
A10BJ06 |
Novo Nordisk A/S |
|
Ozurdex
|
dexamethasone |
S01BA01 |
Allergan Pharmaceuticals Ireland |
|
Ozzion
|
– |
– |
– |
